1998
DOI: 10.1016/s0167-4943(98)80021-6
|View full text |Cite
|
Sign up to set email alerts
|

Fluoxetine and amitriptyline in elderly depressed patients. A 10-week, double-blind study on course of neurocognitive adverse events and depressive symptoms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 35 publications
0
6
0
Order By: Relevance
“…Five hundred thirty‐four abstracts were identified in the systematic literature search, of which 114 full‐text articles were deemed potentially eligible after scanning all abstracts; 15 of these were deemed eligible for inclusion in the study, and 12 of these studies reported on partial response, 12 on dizziness, three on falls, and two on syncope . (Studies with zero‐zero events were excluded from this count.)…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Five hundred thirty‐four abstracts were identified in the systematic literature search, of which 114 full‐text articles were deemed potentially eligible after scanning all abstracts; 15 of these were deemed eligible for inclusion in the study, and 12 of these studies reported on partial response, 12 on dizziness, three on falls, and two on syncope . (Studies with zero‐zero events were excluded from this count.)…”
Section: Resultsmentioning
confidence: 99%
“…Direct evidence was consistent with indirect evidence for these outcomes. The included trials assessed seven SSRIs and SNRIs: sertraline, venlafaxine, citalopram, paroxetine, duloxetine, fluoxetine, and escitalopram . Six trials comparing any of these seven interventions with trazodone or with amitriptyline or trazodone and amitriptyline with each other were also included to strengthen the network evidence.…”
Section: Resultsmentioning
confidence: 99%
“…All 19 RCTs that did not produce extractable response data found no differences between classes of antidepressants (Altamura et al, 1989a(Altamura et al, ,1989bAther et al, 1985;Biziere and Berger, 1990;Bloeink et al, 1985;De Ronchi et al, 1998;De Vanna et al, 1990;Dunner et al, 1992;Eklund et al, 1985;Feighner et al, 1988;Katona et al, 1999; La Pia , 1992;Mulsant et al, 2001;Pancheri et al, 1994;Pelicier and Schaeffer, 1993;Phanjoo et al, 1991;Rosenberg et al, 2007;Siegfried and O'Connolly, 1986;Smeraldi et al, 1998).…”
Section: Different Efficacy Between Classes Of Antidepressantsmentioning
confidence: 99%
“…An initial weight loss, common to many ◆ antidepressants, is very frequently followed by weight gain. 49 11 MD -Maggioni et al, 2005 50 29 Headache -Chouinard, 1985 51 29 MD + Hecht Orzack et al, 1986 52,b 90 MD + Harris et al, 1986 53 14 MD -Fernstrom and Kupfer, 1988 54 18 MD + Altamura et al, 1989 55 10 MD -Cohn et al, 1990 56 71 MD + Reimherr et al, 1990 57,b 139 MD + Bakish et al, 1992 58,b 52 MD + Beasley et al, 1993 59 71 MD + De Ronchi et al, 1998 60 33 MD -Sacchetti et al, 2002 61 29 MD + Berilgen et al, 2005 62 19 Migraine -Altintoprak et al, 2008 63 20 MD -Imipramine Bremner, 1984 64 20 MD + Frank et al, 1990 65 128 MD + Cohn et al, 1990 56 144 MD + Frank et al, 1992 66 115 MD + Reimherr et al, 1990 57,b 136 MD + Mavissakalian and Perel, 1992 67 19 Anxiety + Balon et al, 1993 68,b 14 PD + Mavissakalian and Perel, 2000 69 66 Anxiety + Shioiri et al, 1993 70 46 MD -Mavissakalian et al, 2002 71 20 Anxiety + Fabre et al, 1995 72,b 212 MD + Mavissakalian, 2003 73 20 Anxiety -Mavissakalian and Perel, 2000 69 77 PD + Silverstone, 2001 74 75 MD -Moosa et al, 2003 75 77 MD + Mavissakalian, 2003 73 20 PD -Clomipramine Beaumont, 1977 76 61 MD -Maina et al, 2004 77 23 Anxiety + Guelfi et al, 1992 78 56 MD -Shioiri et al, 1993 70 31 MD -Nortriptyline Fernstrom and Kupfer, 1988 54 18 MD + Miller et al, 1991 79 30 MD + Weber et al, 2000 80 12 MD + Paradis et al, 1992 …”
Section: For Clinical Usementioning
confidence: 99%